Trial · NCT00759031
Investigation of Dental Plaque and Gingival Index
NCT00759031, Phase 3, Completed, Colgate Palmolive; results first posted 2008-11-25
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Investigation of Dental Plaque and Gingival Index. Trials, record NCT00759031. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00759031
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Investigation of Dental Plaque and Gingival Index
- NCT number
- NCT00759031
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 19 participants, actual
- Lead sponsor
- Colgate Palmolive
- Conditions
- Dental Plaque
- Interventions
- Sodium Monofluorophosphate, Triclosan/Fluoride/Copolymer
- First posted
- 2008-09-25
- Last updated
- 2012-04-13
- Results first posted
- 2008-11-25
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Gingival Margin Plaque Index | 1 day | Scale 0 to 100% of tooth gingival margin covered by plaque. (0=no plaque, 100%=100% of the tooth's gingival margin is covered in plaque). The lower the score less dental plaque is present along the gum line and therefore the better the performance of the study treatment. |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Gingival Margin Plaque Index | 1 day | Units on a scale | MEAN |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Gingival Margin Plaque Index | Fluoride | 15.4 | Standard Deviation 14.74 | Units on a scale | |
| Gingival Margin Plaque Index | Triclosan + Fluoride | 12.81 | Standard Deviation 14.06 | Units on a scale |
Source ClinicalTrials.gov
Participant flow18
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| First Intervention (1 Day) | STARTED | Fluoride 1st, Triclosan +Fluoride 2nd | 10 | |
| First Intervention (1 Day) | STARTED | Triclosan + Fluoride 1st, Fluoride 2nd | 9 | |
| First Intervention (1 Day) | COMPLETED | Fluoride 1st, Triclosan +Fluoride 2nd | 8 | |
| First Intervention (1 Day) | COMPLETED | Triclosan + Fluoride 1st, Fluoride 2nd | 8 | |
| First Intervention (1 Day) | NOT COMPLETED | Fluoride 1st, Triclosan +Fluoride 2nd | 2 | |
| First Intervention (1 Day) | NOT COMPLETED | Triclosan + Fluoride 1st, Fluoride 2nd | 1 | |
| Washout After 1st Intervention (1 Week) | STARTED | Fluoride 1st, Triclosan +Fluoride 2nd | 8 | |
| Washout After 1st Intervention (1 Week) | STARTED | Triclosan + Fluoride 1st, Fluoride 2nd | 8 | |
| Washout After 1st Intervention (1 Week) | COMPLETED | Fluoride 1st, Triclosan +Fluoride 2nd | 8 | |
| Washout After 1st Intervention (1 Week) | COMPLETED | Triclosan + Fluoride 1st, Fluoride 2nd | 8 |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 participant flowAdverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Fluoride | ||
| Total, all-cause mortality | Triclosan + Fluoride | ||
| Total, other adverse events | Fluoride | 0 | 18 |
| Total, other adverse events | Triclosan + Fluoride | 0 | 17 |
| Total, serious adverse events | Fluoride | 0 | 18 |
| Total, serious adverse events | Triclosan + Fluoride | 0 | 17 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Fluoride vs Triclosan + Fluoride: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00759031
GET https://conductscience.org/api/trials/v1/NCT00759031/registered